All Sauce from Weekly Sauce:

Artificial intelligence (AI) technologies like ChatGPT someday may make a big difference for people seeking answers to questions such as “How can I stop smoking?” They may even offer resources to someone who was sexually assaulted. But they’re not quite there yet, a new study reveals. Researchers wanted to see how well ChatGPT performed for…  read on >  read on >

As obesity rises among U.S. kids and teens, the number of weight-loss surgeries is growing, too. Metabolic and bariatric surgeries among 10- to 19-year-olds rose by nearly 20% between 2020 and 2021, after climbing since 2016, a new study finds. The jump is especially notable among those from racially and ethnically diverse backgrounds, who are…  read on >  read on >

A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results. The benefits of wearing these patches — long used as chest pain medication — were modest. They also were short-lived, with any benefits appearing to wear off over time, according to researchers from the…  read on >  read on >

With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin. The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical to import the widely used cancer drug. The Canadian pharmaceutical company Apotex will…  read on >  read on >

MONDAY, June 5, 2023Understanding circumcision can help you speed your baby boy’s healing process and be aware of any complications that may arise. Here, professionals offer advice on what circumcision is, the pros and cons of the procedure, and what happens during a circumcision. Plus, they’ll talk about how long the healing process is and…  read on >  read on >

An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to results presented Sunday at the American Society of Clinical Oncology (ASCO)…  read on >  read on >